Alexander D Boiko

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
    Alexander D Boiko
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center, Stanford University School of Medicine, Stanford, California 94304 5542, USA
    Nature 466:133-7. 2010
  2. ncbi VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration
    Olga V Razorenova
    Department of Radiation Oncology, Center for Clinical Sciences Research, Stanford University School of Medicine, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 108:1931-6. 2011

Research Grants

Collaborators

  • Susan M Swetter
  • IRVING LERNER WEISSMAN
  • Olga V Razorenova
  • Charles K F Chan
  • Sophia B Chernikova
  • Renata Colavitti
  • ADAM KRIEG
  • Amato J Giaccia
  • Elizabeth C Finger
  • MARIANNE BROOME-POWELL
  • Edward Lagory
  • Barbara Bedogni

Detail Information

Publications2

  1. ncbi Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
    Alexander D Boiko
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center, Stanford University School of Medicine, Stanford, California 94304 5542, USA
    Nature 466:133-7. 2010
    ....
  2. ncbi VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration
    Olga V Razorenova
    Department of Radiation Oncology, Center for Clinical Sciences Research, Stanford University School of Medicine, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 108:1931-6. 2011
    ..Furthermore, patient survival can be stratified by CDCP1 expression at the cell surface of the tumor. Taken together, our data indicates that CDCP1 protein might serve as a therapeutic target for CC-RCC...

Research Grants1

  1. Isolation and Characterization of Melanoma Tumor Stem Cells
    ALEXANDER BOIKO; Fiscal Year: 2007
    ..These procedures can be designed to specifically irradicatge all of MTSCs and thus improve patient survival rate and functional outcome of tumor therapy. ..